Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin

Clinical Microbiology and Infection

Volumn 8, Issue 6, 2002, Pages 373-380

  Clark, C L ^a   Nagai, K ^a   Davies, T A ^a   Bozdogan, B ^a   Dewasse, B ^a   Jacobs, M R ^b   Appelbaum, P C ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

BMS 284756; Pneumococci resistance selection

Indexed keywords

BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; GARENOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PHENETICILLIN; QUINOLONE DERIVATIVE; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CELL CLONE; CONTROLLED STUDY; GENE MUTATION; IN VITRO SELECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036592635     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00405.x     Document Type: Article

References (19)

1. Antimicrobial resistance in Streptococcus pneumoniae-an overview
2. Antibiotic-resistant pneumococci
3. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management
4. Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States
5. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: Characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis
6. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae
7. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin and vancomycin by using time-kill methodology
8. In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae
9. In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae
10. In vitro selection of resistance to clinafloxacin, ciprofloxacin and trovafloxacin in Streptococcus pneumoniae
11. In vitro and in vivo antimicrobial activities of T-3811ME, a novel Des-F(6)-quinolone
12. Anti-bacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
13. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
14. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae
15. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
16. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong
17. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
18. Fluoroquinolone resistance in Streptococcus pneumoniae